ESR1 and breast cancer: BC is a heterogeneous and complex disease,consisting of multiplehistological and molecular subtypes, with different responses to therapyand clinical outcomes., Currently, from a molecular pointof view, clinical practice has considered the expression of threemain receptors, including estrogen receptor (ER), progesterone receptor(PR), and human epidermal growth factor receptor 2 (HER2).